Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Studies

This site acts as the main hub for several of our current studies.

Studies on this site:

Funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference RP-PG-1209-10051)

Telemonitoring and/or self-monitoring of blood pressure in hypertension

This work is funded by the Medical Research Council (Grant reference: MR/K022032/1)

Prospective Register Of patients undergoing repeated OFfice and Ambulatory Blood Pressure Monitoring (PROOF-ABPM)

Funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference RP-PG-1210-12012)

The early use of Antibiotics for 'at Risk' CHildren with InfluEnza (ARCHIE) - For Health Professionals

The trial is funded by the National Institute for Health Research, Oxford Collaboration for Leadership in Applied Health Research and School for Primary Care Research.
Ethics Ref: 16/SC/0628.
EudraCT Number: 2016-004236-38.

OPtimising Treatment for MIld Systolic hypertension in the Elderly

Treating type 2 diabetes can help to prevent complications and early death. However, between a third and half of the medicines used to treat this condition are not taken as prescribed. Taking tablets as intended can be challenging. Concerns range from worries about treatment to practical difficulty in taking medication several times a day.
The SuMMiT-D study is a six-year NIHR funded programme to develop a digital-health messaging tool to support people with type 2 diabetes in best use of medicines and to test it as part of a wider system of support in clinical trials.

Support through Mobile Messaging and digital health Technology for Diabetes

Studies

Commercially available technologies: